Health

  • May 19, 2026

    Groq, Doctor Strike Deal To End 'Groq Health' TM Suit

    Silicon Valley chipmaker Groq has reached a settlement to end a trademark infringement case it brought in New York federal court against an endocrinologist with a similarly named company.

  • May 19, 2026

    CDC Imposes Entry Restrictions For Ebola Outbreak

    The Centers for Disease Control and Prevention invoked an emergency public health law Monday to impose entry restrictions for non-U.S. passport holders who have been in Uganda, the Democratic Republic of Congo, or South Sudan in the prior three weeks due to an Ebola outbreak.

  • May 18, 2026

    Boeing Owed Duty To Worker's Future Kid, Wash. Panel Says

    Boeing must face claims that a factory worker's on-the-job chemical exposure caused birth defects in his child, a Washington Court of Appeals panel said in a published ruling Monday, finding that an employer "may be liable for negligence towards an employee's not-yet-conceived offspring."

  • May 18, 2026

    Fla. Hospitals Seek $10.5M In Fees In Safety Rating Fight

    Community hospitals owned by Tenet Healthcare Corp. sought $10.5 million in fees they said were warranted in their successful Florida Deceptive and Unfair Trade Practices Act case against hospital ratings nonprofit Leapfrog, while the nonprofit called the request "grotesquely inflated" and premature.

  • May 18, 2026

    Woman Says Spinal Device Caused Permanent Nerve Damage

    The maker of a spinal cord stimulation technology to treat chronic pain faces a federal lawsuit from a Colorado woman who claims that the technology caused her permanent nerve damage and that the device has unacceptable rates of failure nationwide.

  • May 18, 2026

    Fla. Hospital Patients Denied Rethink On Class Cert.

    A Florida federal judge refused to rethink her decision denying class certification for consumers accusing Health First Inc. of locking in patients and blocking competition from rival hospital systems, dinging the plaintiffs for raising arguments they could've asserted earlier and for altering a quote from a cited case.

  • May 18, 2026

    Health Co. Wants Kirkland Off IP Case For 'Cardinal Sin'

    A healthcare company suing medical technology company Commure Inc. over alleged trade secret theft has said Kirkland & Ellis LLP should be disqualified from representing Commure because the healthcare company had tried to retain Kirkland prior to filing the suit and shared confidential information before anyone asked who the defendant was going to be.

  • May 18, 2026

    Ill. Panel Sides With AbbVie In Eye-Stent Injury Suit

    An Illinois appeals panel on Monday affirmed summary judgment in favor of AbbVie in a suit alleging one of its eye stents caused a man's eye injuries, finding the patient failed to present any evidence that his symptoms were a result of the product's manufacturing or design.

  • May 18, 2026

    Senior Home Says Colo. Is Right Venue For Insurance Dispute

    The owner of a Kansas-based senior living community said its claims that its insurer failed to pay over $7 million in damages it suffered when a sprinkler burst must stay in Colorado, according to a pair of briefs filed in Colorado federal court Friday.

  • May 18, 2026

    Justices Won't Revive LA Schools COVID Vaccine Policy Suit

    The U.S. Supreme Court on Monday declined to review whether the Los Angeles Unified School District's COVID-19 vaccine mandate for employees passes constitutional muster, keeping in place the Ninth Circuit's ruling that relied on a 121-year-old high court precedent upholding a city's smallpox vaccine policy.

  • May 18, 2026

    Pa. High Court Snapshot: Wegmans, PennDot Top May Lineup

    The Pennsylvania Supreme Court's May session begins Tuesday with an argument whether the state's Department of Transportation can be sued over a tree branch that fell onto a state road, even though the tree itself was growing from Southeastern Pennsylvania Transportation Authority property.

  • May 18, 2026

    PBMs Tell Mich. Court They're Not To Blame For Opioid Abuse

    Pharmacy benefit managers told a Michigan federal court on Monday they are not responsible for opioid abuse because they do not control prescription drugs once they are sold to patients, as Evernorth Health, Express Scripts and other companies seek an exit from the state attorney general's public nuisance suit.

  • May 18, 2026

    Aetna Denied A Freeze On Trans Facial Surgery Order

    A Connecticut federal judge ordered Aetna to comply with a preliminary injunction requiring it to reconsider coverage denials affecting two transgender health plan participants who sought gender-affirming facial surgery, refusing to stay the insurer's compliance obligations during its pending appeal in the proposed class action.  

  • May 18, 2026

    Hawaiian Scholarship Suit Imperils $2.2M In Work, Court Told

    An Indigenous nonprofit is seeking to intervene as a defendant in a constitutional challenge to the Native Hawaiian Health Scholarship Program, telling a federal district court that the litigation threatens $2.2 million of annual work that's central to its mission and will impede ongoing collaborations for the upcoming fiscal year.

  • May 18, 2026

    Boies Schiller, Firm Partner Dropped From Fla. Fee Suit

    Boies Schiller Flexner LLP and a firm partner have been dismissed as defendants in a Florida state lawsuit brought by a pharmaceutical mass tort law firm and other parties that alleged they breached a nondisclosure agreement and interfered with business relationships.

  • May 18, 2026

    ADA Suit Can't Seek Rewrite Of Psilocybin Law, Ore. Says

    Oregon's health regulator has urged a federal judge to reject a bid to expand access to regulated psilocybin services to homebound patients, saying the relief sought by plaintiffs would mark a "fundamental alteration" of the program.

  • May 18, 2026

    Morgan & Morgan Atty Barred From Harvard Suit Over AI Error

    A Massachusetts judge on Monday said a Morgan & Morgan PA attorney may not appear before him in a suit against Harvard University over the theft of body parts donated to its medical school, saying the lawyer did not learn his lesson after signing off on briefs in another case with fake case law generated by artificial intelligence.

  • May 18, 2026

    Takeda Liable In IBS Drug Pay-For-Delay Trial

    A federal jury in Boston on Monday found Takeda Pharmaceuticals conspired with a generic-drug maker to delay the launch of a generic version of Takeda's anti-constipation drug, awarding purchasers $885 million, a figure that's expected to swell after a rule tripling plaintiffs' antitrust damages is applied.

  • May 18, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week handled a broad mix of celebrity estate litigation, merger disputes, investor suits, record demands, sanctions fights and questions over corporate moves away from Delaware.

  • May 18, 2026

    Justices Deny Eli Lilly's Qui Tam Constitutional Challenge

    The U.S. Supreme Court on Monday declined to review Eli Lilly's $183 million trial loss to a whistleblower who claimed the drugmaker knowingly defrauded the government by underpaying Medicaid drug rebates.

  • May 18, 2026

    Revised Suit Against Healthcare Data Co. Still Fails, Court Told

    A former healthcare data platform chief strategy officer's amended complaint against the employer failed again to justify bringing three out-of-state individuals into the litigation, the company told a North Carolina federal court, adding that several key claims remain flawed.

  • May 18, 2026

    Colo. Justices Tell Hospital To Resume Gender-Affirming Care

    The Colorado Supreme Court ordered Children's Hospital Colorado on Monday to resume its provision of gender-affirming care for transgender youth patients, finding the patients demonstrated actual harm from the denial of care.

  • May 18, 2026

    Mangione Can Suppress Some Evidence In NY Murder Case

    A New York judge on Monday narrowed the evidence state prosecutors may use in their murder case against Luigi Mangione, ruling that a gun and silencer may be allowed into trial but not some items found during an illegal search of his backpack and certain statements to law enforcement.

  • May 18, 2026

    High Court Spurns Pharma Challenges To IRA Drug Price Talks

    The U.S. Supreme Court rejected six petitions Monday from pharmaceutical giants seeking to bring down the Medicare drug price negotiations established as part of the Inflation Reduction Act three years ago.

  • May 15, 2026

    Pharmacies Stuck With CVS Arbitration Mandate At 9th Circ.

    A Ninth Circuit panel refused Friday to let four independent pharmacies avoid arbitrating their antitrust claims that CVS exploited a Medicare loophole to charge them exorbitant fees, standing by a district court's conclusion that just because parts of the arbitration agreement were unconscionable doesn't negate the entire thing.

Expert Analysis

  • Opinion

    AI-Assisted Arbitration Needs Safeguards To Ensure Fairness

    Author Photo

    As tribunals and arbitral institutions increasingly use artificial intelligence tools in their decision-making processes, ​​​​​​​clear disclosure standards and procedural safeguards are necessary to ensure that efficiency gains do not erode the fairness principles on which arbitration depends, says Alexander Lima at Wesco International.

  • Trans Care Enforcement Landscape Is Evolving Quickly

    Author Photo

    The recent coordinated federal effort to reshape pediatric gender-affirming care through enforcement and funding pressure has created a rapidly evolving regulatory environment marked by shifting risk assessments and potential downstream market effects for healthcare institutions and life sciences companies, say attorneys at Arnall Golden.

  • Series

    Playing Piano Makes Me A Better Lawyer

    Author Photo

    Playing piano and practicing law share many parallels relating to managing complexity: Just as hearing an entire musical passage in my head allows me to reliably deliver the message, thinking about the audience's impression helps me create a legal narrative that keeps the reader engaged, says Michael Shepherd at Fish & Richardson.

  • 11th Circ. May Bring Tectonic Shift To FCA Qui Tam Actions

    Author Photo

    The Eleventh Circuit's upcoming decision in Zafirov v. Florida Medical Associates, assessing whether the False Claims Act permits ordinary citizens to stand as officers of the federal government, could significantly limit private relators' ability to bring FCA actions, say attorneys at Saul Ewing.

  • AI-Generated Doc Ruling Guides Attys On Privilege Risks

    Author Photo

    A New York federal court's ruling, in U.S. v. Heppner, that documents created by a defendant using an artificial intelligence tool were not privileged, can serve as a guide to attorneys for retaining attorney-client or work-product privilege over client documents created with AI, say attorneys at Sher Tremonte.

  • To Survive FCA Actions, Small Cos. Must Take Offensive Steps

    Author Photo

    A fumbled response to False Claims Act allegations can doom lower-middle-market businesses, and with FCA enforcement hitting record levels for two years, smaller companies must have offensive strategies ready that focus their limited resources on defeating civil qui tam and federal criminal actions, says Derrelle Janey at Olshan Frome.

  • The Law Firm Merger Diaries: Leadership Strategy After Day 1

    Author Photo

    For law firm leaders, ensuring a newly combined law firm lives up to its promise, both in its first days of operation and well after, includes tough decisions, clear and specific communication, and cheerleading, says Peter Michaud at Ballard Spahr.

  • How US Liability Law Is Becoming The Primary Regulator Of AI

    Author Photo

    Comprehensive federal AI regulation remains fragmented and uncertain — but U.S. courts, applying long-standing doctrines of liability and responsibility, are actively shaping how AI systems are designed, deployed and governed, and companies are aligning their AI practices because courts may hold them accountable if they do not, says Alexander Lima at Wesco International.

  • Record FCA Recoveries Signal Intensified Healthcare Focus

    Author Photo

    In its recently released False Claims Act statistics, the U.S. government's emphasis on record healthcare recoveries and government-initiated healthcare matters last year indicates robust enforcement ahead, though the administration's focus on current policy objectives also extends beyond the healthcare sector, say attorneys at Epstein Becker.

  • Fed. Circ. In Jan.: On The Validity Of Expert Testimony

    Author Photo

    The Federal Circuit's recent decision in Barry v. DePuy, addressing whether expert testimony is admissible even if it does not strictly adhere to the court's claim construction, suggests that exclusion via a Daubert motion is appropriate only when the line to improper testimony is clearly crossed, say attorneys at Knobbe Martens.

  • Methods For Challenging State Civil Investigative Demands

    Author Photo

    Ongoing challenges to enforcement actions underscore the uphill battle businesses face in arguing that a state investigation is prohibited by federal law, but when properly deployed, these arguments present a viable strategy to resist civil investigative demands issued by state attorneys general, say attorneys at Troutman Pepper.

  • Calif.'s Civility Push Shows Why Professionalism Is Vital

    Author Photo

    The California Bar’s campaign against discourteous behavior by attorneys, including a newly required annual civility oath, reflects a growing concern among states that professionalism in law needs shoring up — and recognizes that maintaining composure even when stressed is key to both succeeding professionally and maintaining faith in the legal system, says Lucy Wang at Hinshaw.

  • A Potential Shift In FDA's Approach To Drug Trial Design

    Author Photo

    Recent guidance released by the U.S. Food and Drug Administration clarifying how Bayesian approaches — which combine prior knowledge with new data — may be used in clinical trials reflects the agency's continued interest in innovative trial designs that may accelerate drug approvals, say attorneys at Alston & Bird.

  • Opinion

    SNAP Rule Confusion Risks A Compliance Crisis

    Author Photo

    Recent Supplemental Nutrition Assistance Program food restriction waivers pose a compliance crisis for legal practitioners advising food retailers, amid higher costs and lack of a coherent national standard, says Tyson-Lord Gray at Yeshiva University’s Benjamin N. Cardozo School of Law.

  • Series

    Trivia Competition Makes Me A Better Lawyer

    Author Photo

    Playing trivia taught me to quickly absorb information and recognize when I've learned what I'm expected to know, training me in the crucial skills needed to be a good attorney, and reminding me to be gracious in defeat, says Jonah Knobler at Patterson Belknap.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.